文献速递血脂与心血管预防高血压

非心脏手术中目标更高术中血压未能减少不良心血管事件

Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

该单中心随机对照试验纳入458例心血管风险成人非心脏手术患者,比较术中平均动脉压目标≥75 mmHg与≥60 mmHg对术后结局的影响。结果显示,更高血压目标虽显著缩短低血压时间,但未显著降低急性心肌损伤或30天主要不良心血管事件/急性肾损伤发生率。

要点

  • 术中平均动脉压目标≥75 mmHg未显著降低术后急性心肌损伤或30天MACE/AKI。
  • 更高目标组MAP<65 mmHg累计时间中位数9分钟,显著短于对照组的23分钟。
  • 主要结局发生率48% vs 52%,风险差-4.2%(95%CI -13%至+5%),无统计学意义。

核心结论

  • 不支持对所有心血管风险患者普遍采用更高的术中血压目标来减少术后并发症。

研究设计与样本

  • 单中心随机对照试验,纳入458例心血管风险成人非心脏大手术患者,意向性治疗分析451例。
  • 患者随机分配至术中平均动脉压目标≥60 mmHg(对照组)或≥75 mmHg(MAP≥75组)。

主要发现

  • MAP≥75组术中MAP<65 mmHg累计时间中位数9分钟(IQR 3-24),对照组23分钟(IQR 8-49),P<0.001。
  • 主要结局(术后0-3天急性心肌损伤和/或30天MACE/AKI)发生率MAP≥75组48%,对照组52%,风险差-4.2%(95%CI -13%至+5%)。
  • 急性心肌损伤发生率MAP≥75组15%,对照组19%;主要贡献为AKI(发生率44%)。
  • 次要结局1年MACE发生率MAP≥75组17%,对照组15%,风险差+2.7(95%CI -4%至+9.5%)。

临床怎么用

  • 对于心血管风险患者行非心脏大手术,不应仅以追求更高术中平均动脉压为目标来预防术后MACE或AKI。
  • 术中低血压时间缩短未转化为临床结局获益,提示血压管理需综合评估而非单一阈值导向。

局限性

  • 单中心设计可能限制结果外推性。
  • 意向性治疗分析样本量为451例,事件数可能影响统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intraoperative arterial hypotension is strongly associated with postoperative major adverse cardiovascular events (MACE); however, whether targeting higher intraoperative mean arterial blood pressures (MAPs) may prevent adverse events remains unclear. OBJECTIVES: This study sought to determine whether targeting higher intraoperative MAP lowers the incidence of postoperative MACE. METHODS: This single-center randomized controlled trial assigned adult patients at cardiovascular risk undergoing major noncardiac surgery to an intraoperative MAP target of ≥60 mm Hg (control) or ≥75 mm Hg (MAP ≥75). The primary outcome was acute myocardial injury on postoperative days 0-3 and/or 30-day MACE/acute kidney injury (AKI) (acute coronary syndrome, congestive heart failure, coronary revascularization, stroke, AKI, and all-cause mortality). The secondary outcome was 1-year MACE. RESULTS: In total, 458 patients were randomized (intention-to-treat population: 451). The cumulative intraoperative duration with MAP <65 mm Hg was significantly shorter in the MAP ≥75 group (median 9 minutes [interquartile range: 3 to 24 minutes] vs 23 minutes [interquartile range: 8-49 minutes]; P < 0.001). The primary outcome incidence was 48% for MAP ≥75 and 52% for control (risk difference -4.2%; 95% CI: -13% to +5%), the primary contributor being AKI (incidence 44%). Acute myocardial injury occurred in 15% (MAP ≥75) and 19% (control) of patients. The secondary outcome incidence was 17% for MAP ≥75 and 15% for control (risk difference +2.7; 95% CI: -4% to +9.5%). CONCLUSIONS: These findings do not support universally targeting higher intraoperative blood pressures to reduce postoperative complications. Despite a 60% reduction in hypotensive time with MAP <65 mm Hg, no significant reductions in acute myocardial injury or 30-day MACE/AKI could be found. (Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery [BBB]; NCT02533128).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Wanner PM, Wulff DU, Djurdjevic M, et al. Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery. J Am Coll Cardiol. 2021. PMID: 34711333. doi:10.1016/j.jacc.2021.08.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。